Kasugamycin Hydrochloride PRODUCT DATA SHEET Issue Date 01/06/2020

Kasugamycin Hydrochloride PRODUCT DATA SHEET Issue Date 01/06/2020

Kasugamycin hydrochloride PRODUCT DATA SHEET issue date 01/06/2020 Product Name: Kasugamycin hydrochloride Product Number: K005 CAS Number: 19408-46-9 Molecular Formula: C14H25N3O9 · HCl Molecular Weight: 415.82 Form: Powder Appearance: White crystalline powder Solubility: is freely soluble in aqueous solution. Source: Streptomyces kasugaensis Melting Point: 203 °C Storage Conditions: 2­8 °C Description: Kasugamycin hydrochloride is a salt form a Kasugamycin, is a broad- spectrum antibacterial and antifungal aminoglycoside originally isolated in 1965 from Streptomyces kasugaensis found near the Kasuga shrine in Japan. This natural product used against yeast and pathogenic fungi such as M. grisea. Kasugamycin is freely soluble in aqueous solution. Mechanism of Action: Like many of the known natural antibiotics, kasugamycin inhibits proliferation of bacteria by tampering with their ability to make new proteins, the ribosome being the major target. Kasugamycin inhibits protein synthesis at the step of translation initiation by direct competition with initiator transfer RNA. Plant Biology In rice models, kasugamycin is used to prevent and cure M. grisea mycelia Applications formation with <20 µg/mL. In addition, kasugamycin has shown to suppress a number of plant parasitic infections such as leaf spot and apple scab. Kasugamycin is preferentially used over other antifungals due to its lower phytoxicity and toxicity to animals. References: Masukawa H, Tanaka N, Umezawa H. (1968) Inhibition by kasugamycin of protein synthesis in Piricularia oryzae. J Antibiot (Tokyo). 21(1):73-74 PMID 4970570 Ochi K et al (2008 ) Inactivation of KsgA, a 16S rRNA Methyltransferase, causes vigorous emergence of mutants with high-Level Kasugamycin resistance. Antimicrob. Agents. Chemother. 53 (1): 193-201 Surkov S et al (2010) Translation initiation region dependcey fo translation initiation in Escherichia coli by IF1 and kasugamycin. FEBS J. 277 (11):2428- 2439 If you need any help, contact us: [email protected]. Find more information on: www.toku-e.com/.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us